Human ErbB4 quantitates human ErbB4 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human ErbB4.
Human ErbB4 quantitates human ErbB4 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human ErbB4.
ErbB 4 (Her-4, c-erbB-4, v-erbB-4) is part of the class I kinase receptor family. With over 500 genetic products, the kinase protein family is one of the largest eukaryote protein families. The family was classified in 8 large groups based on the comparison of the sequences of their catalytic domains of tyrosine kinase (PTK) or serine/threonine (STK). The ErbB 4 is activated by neureguines and NTAK (neural and thymus-derived activator for ErbB kinases). The ErbB 4 is a receptor for the heregline and is able to mediate the phosphorylation of tyrosine stimulated by HGL. Like other kinase proteins, L-ErbB 4 mediates most signal transductions in eukaryotic cells, regulating cell metabolism, transcription, cell cycle progression, cytoskeleton rearrangement, and cell movement, apoptosis, and differentiation. The main expression of L-ErbB 4 is in several breast cancer cell lines and in normal skeletal muscle, heart, pituitary, brain, and cerebellum. Cell lines of breast tumours T47-D, MDA-MB-453, BT-474 and H3396 have the highest levels of mRNA and intermediate levels are observed in MCF-7, MDAMB-330 and MDA-MB-361. The expression of the ErbB 4 is weak or absent in certain cell lines of breast tumours such as MDA-MB-231, MDA-MB-157, MDA-MB-468 and SKBR-3. The levels of d的ErbB 4 were elevated in some human tumour cell lines, suggesting that they may play a role in some malignancies.
Sensitivity
Sensitivity of the assay: 0.2 ng/mL.
Measurement range
Dose range: 0.2 to 50 ng/mL.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Samples
Type of sample: Plasma, Serum, Surnatant (surnatant volume, 50 µl; plasma, 50 µl; serum, 50 µl).
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 17134929 |
| Specifications |
| Accession number | 4 ICD; ALS19; viral avian erythroblast leukaemia (v-erb-b2) oncogenes homologous 4; oncogenous avian erythroblastosis B 4; c-erbB-4; receptor of l'erb-b2 tyrosine kinase 4; erbB4; intracellular domain of l'erbB4; variant of transcription of l'erbB4; variant of transcription of l'erbB4 |
| Dose range | 0.2 to 50 ng/mL |
| Sensitivity of the dosage | 0.2 ng/mL |
| Conjugate | Biotin |
| Product type | ELISA |
| Type of sample | Plasma, Serum, Surnatant |
| For use with (equipment) | Colorimetric microplate reader |
| Genetic identification (Enter) | Q15303 |
| Gene symbol(s) | ERBB4 |
| Coefficient of inter-dose variation | <12% |
| Coefficient of intra-dose variation | <10% |
| Contents of kits | Pre-coated well plate, standard, dosing diluent concentrate, biotinylated detection antibody, SAV-HRP, washing pad, chromogen, stop solution, adhesive plate lids |
| Marker or dye | HRP |
| Quantity | 5 x 96 tests |
| Regulatory status | Use exclusively for research |
| Target | ErbB4 |
| Test time | 1 h 20 min |
| Physical characteristics |
| Volume of sample | Supernatant, 50 µl; plasma, 50 µl; serum, 50 µl |
| Storage and shipping |
| Storage conditions | 2°C to 8°C |
| Total duration of dosing | 4 h 45 min |
Origin and customs
| Manufacturer ref. | EH175RBX5 |
|---|
| Country of origin | United States |
|---|
A question or a specific configuration?
Contact us for a quote.